This article was written by Follow With a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines, and market...
2025 trading behavior prominently featured momentum. Certain categories of stocks soared to new heights while others were left in the dust. Toward the end...
In late December, I recommended Vir Biotechnology, Inc. (NASDAQ:VIR) as a speculative Buy due to its long-term cash availability, experienced management team, collaborations with...
Research Brief Recently, my focus on the “innovation” & “managed services” sector turned towards a specific niche: federal contractors specializing in aerospace, homeland security,...
Alibaba (NYSE:BABA) is rapidly diversifying its revenue base which will help the company reduce China-centric headwinds and build a longer growth runway. In the...